BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31858537)

  • 61. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
    Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MiR-24-1-5p Hinders Malignant Phenotypes of Clear Cell Renal Cell Carcinoma by Targeting SHOX2.
    Zhou J; Li P; Feng J; Wu Q; You S
    Biochem Genet; 2023 Oct; 61(5):2004-2019. PubMed ID: 36917325
    [TBL] [Abstract][Full Text] [Related]  

  • 63. LINC01308 accelerates the malignant progression of ovarian cancer by binding to miRNA-506.
    Zhang YY; Li P; Zhu MZ; Guo Y; Yang J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3253-3260. PubMed ID: 31081077
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Upregulation of MIAT Regulates LOXL2 Expression by Competitively Binding MiR-29c in Clear Cell Renal Cell Carcinoma.
    Qu Y; Xiao H; Xiao W; Xiong Z; Hu W; Gao Y; Ru Z; Wang C; Bao L; Wang K; Ruan H; Song Z; Chen K; Zhang X; Yang H
    Cell Physiol Biochem; 2018; 48(3):1075-1087. PubMed ID: 30041179
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
    Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
    BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long non-coding RNA LINC00565 regulates
    Meng B; Wang P; Zhao C; Yin G; Meng X; Li L; Cai S; Yan C
    Chin J Physiol; 2023; 66(6):474-484. PubMed ID: 38149560
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
    Huang JL; Liao Y; Qiu MX; Li J; An Y
    Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
    Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W
    Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539.
    Wang R; Zheng B; Liu H; Wan X
    Cell Cycle; 2020 May; 19(10):1122-1131. PubMed ID: 32286142
    [TBL] [Abstract][Full Text] [Related]  

  • 70. LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression.
    Deng H; Huang C; Wang Y; Jiang H; Peng S; Zhao X
    Aging (Albany NY); 2019 Aug; 11(16):5975-5991. PubMed ID: 31434797
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comprehensive Analysis of N6-Methylandenosine-Related lncRNAs in Clear Cell Renal Cell Carcinoma: A Correlation With Prognosis, Tumor Progression, and Therapeutic Response.
    Meng C; Li J; Wang X; Ying Y; Li Z; Wang A; Li X
    Cancer Invest; 2024 Apr; 42(4):278-296. PubMed ID: 38644691
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MicroRNA-155-5p Targets JADE-1, Promoting Proliferation, Migration, and Invasion in Clear Cell Renal Cell Carcinoma Cells.
    Kalantzakos T; Hooper K; Das S; Sullivan T; Canes D; Moinzadeh A; Rieger-Christ K
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175531
    [TBL] [Abstract][Full Text] [Related]  

  • 73. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma.
    He T; Lu C; Gong W; Ge Z; Li R; Li X; Sun C; Li W; Long Q; Liu Q; Lai Y
    Front Biosci (Landmark Ed); 2024 May; 29(5):186. PubMed ID: 38812297
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of Long Noncoding RNA APOC1P1 as an Oncogene in Clear Cell Renal Cell Carcinoma.
    Sun C; Zhou Z; Shi H; Li F; Zhang G
    Dis Markers; 2019; 2019():2814058. PubMed ID: 31871500
    [TBL] [Abstract][Full Text] [Related]  

  • 75. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.
    Ye Y; Zhang F; Chen Q; Huang Z; Li M
    Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma.
    Mu Z; Dong D; Wei N; Sun M; Wang W; Shao Y; Gao J; Yin P; Zhao C
    Oncol Res; 2019 Jun; 27(6):653-661. PubMed ID: 30832752
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
    Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
    Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
    Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
    Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comprehensive profiling of circRNAs and the tumor suppressor function of circHIPK3 in clear cell renal carcinoma.
    Li H; Heng B; Ouyang P; Xie X; Zhang T; Chen G; Chen Z; Cheang K; Lai C
    J Mol Histol; 2020 Jun; 51(3):317-327. PubMed ID: 32409849
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Replisome genes regulation by antitumor miR-101-5p in clear cell renal cell carcinoma.
    Yamada Y; Nohata N; Uchida A; Kato M; Arai T; Moriya S; Mizuno K; Kojima S; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2020 Apr; 111(4):1392-1406. PubMed ID: 31975570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.